Kolosis Attends 2026 Spine Summit

The Kolosis team will be attending the 2026 Spine Summit in Phoenix, Arizona. The Spine Summit meeting is a world-class program featuring industry-leading experts, hands-on workshops and the latest advancements in spinal care. This annual event is hosted by AANS (American Association of Neurological Surgeons), and connects top professionals with experts in the field. Kolosis […]

Kolosis Attends 2026 Life Sciences Day on the Hill at the Utah State Capitol

Kolosis was honored to attend the 2026 Life Sciences Day on the Hill event at the Utah State Capitol this week. The Kolosis team hosted a booth and showcased their innovative biologics to legislators and other biotech companies headquartered in Utah. This event features exhibits from local life science companies in the capitol rotunda. This […]

Kolosis Attends 2026 STS Annual Meeting

The Kolosis team will be attending the 2026 STS (Society of Thoracic Surgeons) Annual Meeting in New Orleans, Louisiana. The STS Annual Meeting is a premier event in cardiothoracic surgery, featuring cutting-edge education, scientific research, and interdisciplinary collaboration. This annual meeting brings together leading surgeons, clinicians, and industry experts to explore emerging trends, innovations, and […]

Kolosis Recognized as a Fastest Growing Company by Utah Business Magazine

Salt Lake City, UT — Kolosis is proud to announce that they have been awarded 8th place on Utah Business magazine’s 2025 Fast 50 list of the state’s fastest-growing companies. The Fast 50 recognizes Utah companies five years or older that demonstrate both high revenue growth and strong overall revenue performance. This marks the third consecutive […]

MTF Biologics and Kolosis BIO Launch Two New Allografts to Advance Cardiac Surgery

(BUSINESS WIRE) MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of biologic solutions, today announced they have partnered to bring two innovative allograft tissues to cardiac surgeons: ATLAS™ Sternal Repair Matrix for sternal fusion and IKON™ […]

Kolosis Announces the Appointment of Tim Larsen as Chief Financial Officer

Kolosis BIO announced today the appointment of Tim Larsen as Chief Financial Officer. As Chief Financial Officer, Tim is responsible for leading the company’s financial strategy, planning, and infrastructure. He oversees all aspects of finance and accounting, ensuring Kolosis is positioned for scalable, long-term growth. Tim brings over two decades of executive leadership in finance, […]

Kolosis Announces the Appointment of Keely Coughlin as Regional Manager, South

Kolosis BIO announced today the appointment of Keely Coughlin as Regional Manager, South. She brings a strong track record in spine-focused sales and biologics leadership. Prior to joining Kolosis, Keely served as a Senior Spine Specialist at Globus Medical following its acquisition of NuVasive, where she successfully led OR support for more than eight spine […]